RODELIN SUMIRAN: Open Payments
NPI 1790425817 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,426 in 34 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $365 · 2025 $2,426
Travel & lodging: $1,398Food & beverage: $943Education: $85
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $1,843 |
| Janssen Biotech, Inc. | 5 | $241 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| TOLMAR, INC. | 4 | $76 |
| Astellas Pharma US Inc | 2 | $65 |
| Myriad Genetic Laboratories, Inc. | 3 | $56 |
| 180 Medical, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $20 |
Products named: Axonics, ERLEADA, Xtandi, GEMTESA, RYBREVANT, PROLARIS, ELIGARD, JATENZO.
Industry payments across NY — which companies pay providers there.
